Clinical phenotypes in chronic obstructive pulmonary disease

被引:1
作者
Silva O, Rafael [1 ]
机构
[1] Univ Autonoma Chile, Hosp Reg Talca, Fac Ciencias Salud, Serv Med,Unidad Enfermedades Resp, Talca, Chile
关键词
Bronchitis; chronic; Phenotype; Pulmonary disease; chronic obstructive; AIR-FLOW OBSTRUCTION; TERM OXYGEN-THERAPY; COPD PHENOTYPES; MODERATE HYPOXEMIA; ECLIPSE COHORT; DETERMINANTS; ROFLUMILAST; MANAGEMENT; PROGNOSIS; EMPHYSEMA;
D O I
10.4067/S0034-98872012000700016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, that is defined by the degree of obstruction rendered by the forced expiratory volume in the first second (FEV1). This is a good parameter to define the severity of the disease but does not account for its heterogeneity and does not provide a good comprehension of its different clinical behaviors and responses to treatment. Therefore, the classification of these patients in different clinical phenotypes has been attempted, trying to search for common clinical behaviors and responses to treatment. These phenoptypes must be validated in longitudinal studies. Some of the phenotypes detected are COPD with chronic respiratory failure and responsive to home oxygen therapy, COPD with upper lobe emphysema and responsive to volume reduction surgery, COPD with frequent exacerbation behavior, COPD resembling bronchitis and responsive to Roflumilast and possibly, COPD with systemic involvement. Historically, the phenotypes pink puffer, blue bloater, chronic bronchitis were defined. In the next years, we will know if the definitions of these phenotypes will aid in the management of patients with COPD. (Rev Med Chile 2012; 140: 926-933).
引用
收藏
页码:926 / 933
页数:8
相关论文
共 45 条
  • [1] COPD, a multicomponent disease: implications for management
    Agusti, AGN
    [J]. RESPIRATORY MEDICINE, 2005, 99 (06) : 670 - 682
  • [2] Addressing the Complexity of Chronic Obstructive Pulmonary Disease From Phenotypes and Biomarkers to Scale-Free Networks, Systems Biology, and P4 Medicine
    Agusti, Alvar
    Sobradillo, Patricia
    Celli, Bartolome
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (09) : 1129 - 1137
  • [3] Characterisation of COPD heterogeneity in the ECLIPSE cohort
    Agusti, Alvar
    Calverley, Peter M. A.
    Celli, Bartolome
    Coxson, Harvey O.
    Edwards, Lisa D.
    Lomas, David A.
    MacNee, William
    Miller, Bruce E.
    Rennard, Steve
    Silverman, Edwin K.
    Tal-Singer, Ruth
    Wouters, Emiel
    Yates, Julie C.
    Vestbo, Jorgen
    [J]. RESPIRATORY RESEARCH, 2010, 11
  • [4] [Anonymous], 1980, ANN INTERN MED, V93, P391
  • [5] Smoking and lung function of lung health study participants after 11 years
    Anthonisen, NR
    Connett, JE
    Murray, RP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) : 675 - 679
  • [6] ANZUETO A, 2010, AM J RESP CRIT CARE, V181, pA2388
  • [7] Systemic manifestations and comorbidities of COPD
    Barnes, P. J.
    Celli, B. R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) : 1165 - 1185
  • [8] Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
    Burgel, P-R.
    Paillasseur, J-L.
    Caillaud, D.
    Tillie-Leblond, I.
    Chanez, P.
    Escamilla, R.
    Court-Fortune, I.
    Perez, T.
    Carre, P.
    Roche, N.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 531 - 539
  • [9] THE COURSE AND PROGNOSIS OF DIFFERENT FORMS OF CHRONIC AIRWAYS OBSTRUCTION IN A SAMPLE FROM THE GENERAL-POPULATION
    BURROWS, B
    BLOOM, JW
    TRAVER, GA
    CLINE, MG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) : 1309 - 1314
  • [10] Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
    Calverley, Peter M. A.
    Rabe, Klaus F.
    Goehring, Udo-Michael
    Kristiansen, Soren
    Fabbri, Leonardo M.
    Martinez, Fernando J.
    [J]. LANCET, 2009, 374 (9691) : 685 - 694